Healthcare Big Data Analytics, PHR and Data Utilisation
First written in FY2020-Q3. 15 of 32 entries say "Advanced", first in FY2020. Latest entry: 2026-09-18.
6 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In the Health Big Data segment, the company made capital expenditures of ¥3,371 million on additional and replacement servers and system development to support business expansion.」
The company specifically disclosed ¥3,371 million in capital expenditures on additional and replacement servers and system development to support the expansion of its Health Big Data business. - FY2026-H1RestatedAnnual report
「The Health Big Data segment provides data analytics services using data held by insurers, including health insurance societies, to support their health management programs, as well as PHR services developed by the company. It also provides medical data analytics services, medical reimbursement factoring services and drug databases to medical institutions. In addition, anonymized processed information received in connection with these operations is compiled into databases for academic and industrial use.」
The company continues to offer insurer data analytics, PHR, medical data analytics, medical reimbursement factoring and drug databases for medical institutions, and the database development and academic and industrial use of anonymized processed information. - FY2025RestatedAnnual report
「The Health Big Data segment provides data analytics services using data held by health insurance societies and other insurers to support their health management programs, as well as PHR services developed by the company.」
The company restated its continuing business offerings of insurer data analytics, PHR, data services for medical institutions, and the database development and utilization of anonymized processed information. - FY2024-Q3RestatedAnnual report
「The Health Big Data segment provides data analytics services using data held by insurers, including health insurance societies, to support their health management programs, as well as PHR services developed by the company. It also provides medical data analytics services, medical reimbursement factoring services and drug databases to medical institutions. In addition, anonymized processed information received in connection with these operations is compiled into databases for academic and industrial use.」
The company continues to offer insurer data analytics, PHR, medical data analytics, medical reimbursement factoring and drug databases for medical institutions, and the database development and academic and industrial use of anonymized processed information. - FY2024-Q2RestatedAnnual report
「The Health Big Data segment provides data analytics services using data held by insurers, including health insurance societies, to support their health management programs, as well as PHR services developed by the company. It also provides medical data analytics services, medical reimbursement factoring services and drug databases to medical institutions. In addition, anonymized processed information received in connection with these operations is compiled into databases for academic and industrial use.」
The company continues to offer insurer data analytics, PHR, medical data analytics, medical reimbursement factoring and drug databases for medical institutions, and the database development and academic and industrial use of anonymized processed information. - FY2024-Q1RestatedAnnual report
「The Health Big Data segment provides data analytics services using data held by insurers, including health insurance societies, to support their health management programs, as well as PHR services developed by the company. It also provides medical data analytics services, medical reimbursement factoring services and drug databases to medical institutions. In addition, anonymized processed information received in connection with these operations is compiled into databases for academic and industrial use.」
The company continues to offer insurer data analytics, PHR, medical data analytics, medical reimbursement factoring and drug databases for medical institutions, and the database development and academic and industrial use of anonymized processed information. - FY2023-Q3RestatedAnnual report
「The Health Big Data segment provides data analysis services for data held by insurers, mainly health insurance societies, to support their health programs, as well as our internally developed PHR service. We also provide medical data analysis services, medical reimbursement factoring services, and drug databases to medical institutions. In addition, we database the anonymized processed information received in connection with these operations and promote its academic and industrial use.」
The company continues to offer health insurance data analytics, PHR, medical data analytics, medical reimbursement factoring and drug databases for medical institutions, and the database development and academic and industrial use of anonymized processed information. - FY2023-Q2AdvancedAnnual report
「During the six months ended the second quarter, the company substantially expanded its medical institution-sourced data by making Real World Data Co., Ltd. and other companies subsidiaries, and began efforts to provide services in new areas such as clinical trials.」
The company substantially expanded its medical institution-sourced data by making Real World Data Co., Ltd. and other companies subsidiaries, and began providing services in new areas such as clinical trials. - FY2023-Q1AdvancedAnnual report
「At a Board of Directors meeting held on 12 July 2022, the company resolved to acquire the shares of Real World Data Co., Ltd. and make it a subsidiary, and completed the acquisition of all shares on 29 July 2022. The objective is to expand existing businesses and enter the clinical trials field by using electronic medical record and other data, primarily from large medical institutions.」
The company completed the acquisition of all shares of Real World Data Co., Ltd. and reported concrete progress in adding electronic medical record and other data to its medical big data infrastructure. It also indicated plans to use the data in the clinical trials field in addition to its existing businesses. - FY2022AdvancedAnnual report
「Construction of a healthcare expenditure forecasting statistical model using data covering approximately 10 million people」
Concrete research and development and commercialization of data utilization progressed, including a healthcare expenditure forecasting model using data covering approximately 10 million people, an AI model using claims data covering approximately 13 million cumulative people, and various applications and cloud services. - FY2022-Q3AdvancedAnnual report
「The company is also acquiring new healthcare data, including by exceeding 1 million cumulative individuals represented in the electronic medical record database of clinical laboratory values it provides.」
The company reported concrete progress in its medical data utilization infrastructure, with the cumulative number of individuals represented in its electronic medical record database of clinical laboratory values exceeding 1 million. - FY2022-Q2RestatedAnnual report
「The Health Big Data segment provides data analytics services using data held by health insurance societies to support their health management programs, as well as PHR services developed by the company. It also provides medical data analytics services, medical reimbursement factoring services and drug databases to medical institutions. In addition, anonymized processed information received in connection with these operations is compiled into databases for academic and industrial use.」
The company restated health insurance data analytics, PHR, medical data analytics, medical reimbursement factoring and drug databases for medical institutions, and the database development and academic and industrial use of anonymized processed information as business offerings. - FY2022-Q1RestatedAnnual report
「The Health Big Data segment provides data analytics services using data held by health insurance societies to support their health management programs, as well as PHR services developed by the company. It also provides medical data analytics services, medical reimbursement factoring services and drug databases to medical institutions. In addition, anonymized processed information received in connection with these operations is compiled into databases for academic and industrial use.」
The company continues to offer health insurance data analytics, PHR, medical data analytics, medical reimbursement factoring and drug databases for medical institutions, and the database development and academic and industrial use of anonymized processed information. - FY2021-Q3RestatedAnnual report
「The Health Big Data segment provides data analytics services using data held by health insurance societies to support their health management programs, as well as PHR services developed by the company. It also provides medical data analytics services, medical reimbursement factoring services and drug databases to medical institutions. In addition, anonymized processed information received in connection with these operations is compiled into databases for academic and industrial use.」
The company restated health insurance data analytics, PHR, medical data analytics, medical reimbursement factoring and drug databases for medical institutions, and the database development and academic and industrial use of anonymized processed information as business offerings. - FY2021-Q1RestatedAnnual report
「In addition to data analytics services using data held by health insurance societies, we provide PHR services developed by the company. We also compile anonymized processed information received in connection with these operations into databases and promote its academic and industrial use.」
The company reaffirmed health insurance data analytics, PHR, and the database development and academic and industrial use of anonymized processed information as offerings of its medical big data business. - FY2020AdvancedAnnual report
「We are building medical big data from anonymized processed data, including claims data, health screening data and register data. As of the end of March 2020, data covering approximately 7.5 million people could be tracked over time.」
The company reported concrete progress in building medical big data, with data covering approximately 7.5 million people trackable over time as of the end of March 2020. - FY2020-Q3First statedAnnual report
「The Health Big Data business provides data analytics services using data held by health insurance societies to support their health management programs, as well as PHR services developed by the company. In addition, anonymized processed information received in connection with these operations is compiled into databases for academic and industrial use. The company also sells drug databases to medical institutions.」
The company presents health insurance data analytics, PHR, the database development and academic and industrial use of anonymized processed information, and the sale of drug databases to medical institutions as integrated business offerings.